Patients with heterozygous familial hypercholesterolemia caused by mutations in LDLR, APOB, APOE, and PCSK9 show a reduced vulnerability to T2D compared to the general population [29,30]. Here, PCSK9 is linked to type 2 diabetes mellitus.